《花旗银行：2024 GLP-1受体激动剂对肥胖症及其他病症的影响研究报告（英文版）（76页）.pdf》由会员分享，可在线阅读，更多相关《花旗银行：2024 GLP-1受体激动剂对肥胖症及其他病症的影响研究报告（英文版）（76页）.pdf（76页珍藏版）》请在三个皮匠报告上搜索。

1、Citi is one of the worlds largest financial institutions,operating in all major established and emerging markets.Across these world markets,our employees conduct an ongoing multi-disciplinary conversation accessing information,analyzing data,developing insights,and formulating advice.As our premier

2、thought leadership product,Citi GPS is designed to help our readers navigate the global economys most demanding challenges and to anticipate future themes and trends in a fast-changing and interconnected world.Citi GPS accesses the best elements of our global conversation and harvests the thought le

3、adership of a wide range of senior professionals across our firm.This is not a research report and does not constitute advice on investments or a solicitations to buy or sell any financial instruments.For more information on Citi GPS,please visit our website at GPS:Global Perspectives&SolutionsOctob

4、er 2024Obesity and BeyondThe Surprising Reach of GLP-1s Citi GPS:Citi GPS:Global Perspectives&Solutions October 2024 Adam Spielman Head of Health and Consumer Citi Global Insights Filippo Falorni,CFA U.S.Beverages and HPC Citi Equity Research Thomas Palmer,CFA U.S.Food Manufacturers Citi Equity Rese

5、arch Heejin Lim Korea Consumer,Retail and MedTech Citi Equity Research Anjolaoluwa Odunsi Health and Wellness Citi Global Insights Diane Wehner,CFA Senior Portfolio Manager,Healthcare Citi Global Wealth Nathan Weinstein,CFA Global Healthcare Analyst Citi Global Wealth Jim Hollingshead CEO Insulet Pr

6、ashant Agrawal Founder and CEO Impact Analytics Mick Farrell CEO ResMed Carlos M Nunez,MD Chief Medical Officer ResMed October 2024 Citi GPS:Citi GPS:Global Perspectives&Solutions 2024 Citigroup 3 OBESITY AND BEYOND The Surprising Reach of GLP-1s GLP-1 wonder-drugs have crashed into the collective c